Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS)

63 filings reported holding SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (SYRS) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.8M shares of 27.2M outstanding shares and own 65.29% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (2.75M shares), Artal Group S.A. (2.51M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.07M shares), Samsara BioCapital, LLC (1.79M shares), Avidity Partners Management LP (1.67M shares), Point72 Asset Management, L.P. (1.47M shares), Flagship Pioneering Inc. (1.29M shares), Deep Track Capital, LP (828K shares), VANGUARD GROUP INC (765K shares), and Opaleye Management Inc. (359K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.